Technology News and Research

RSS

BARDA awards Vaxin $21.7M contract to accelerate development of novel anthrax vaccine

Vaxin Inc., a clinical stage vaccine development company, today announced that it has been awarded a contract valued at up to $21.7 million by the Office of Biomedical Advanced Research and Development Authority (BARDA) for pre-clinical assessment, final manufacturing process development and the supply of clinical materials to support an IND filing and first-in-man dose ranging study of the company's proprietary anthrax vaccine, AdVAV.

17 Sep 2011

Nanion’s automated patch clamp platforms show unparalleled results using stem cell derived cardiomyocytes

The Patchliner and the SyncroPatch 96 have successfully been used for compound analysis under current- and voltage clamp recording conditions using different stem cell-derived cardiomyocytes. The exceptional cell-platform-compatibility and the unique experimental possibilities offered by Nanion’s platforms open up whole new avenues for compound safety testing.

16 Sep 2011

DryDiapersPlus joins Unique Wellness and BIOTX to provide incontinence products

DryDiapersPlus is excited to announce that they have joined with Unique Wellness and BIOTX Ltd to provide world-class incontinence products for their customers.

16 Sep 2011

Chemical composition of chitosan influences antibacterial activity

The polysaccharide (sugar substance) chitosan has a documented antibacterial effect. Hilde Mellegård's doctoral research shows that this antibacterial activity varies according to the chemical composition of the chitosan.

16 Sep 2011

Life Technologies praises Obama's signing of the America Invents Act

Life Technologies Corporation applauds the signing by President Barack Obama of "The Leahy-Smith America Invents Act" (H.R. 1249). President Obama will sign the bill today at Thomas Jefferson High School for Science and Technology in Alexandria, Virginia.

16 Sep 2011

New collaboration reinforces Sanofi's translational discovery platform for retinal diseases

The Max Planck Society (Max-Planck-Gesellschaft), Germany's leading basic research organization, announced today that it has signed with Fovea Pharmaceuticals, the Ophthalmology Division of Sanofi, a research collaboration and license agreement to identify and develop innovative solutions for restoring vision in patients suffering from diseases affecting the retina.

16 Sep 2011

HHS' BARDA contract advances development of novel anthrax vaccine, antitoxin

The advanced development of a novel next-generation anthrax vaccine and a new type of anthrax antitoxin have received support through new contracts funded the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority.

16 Sep 2011

Mindray launches new DP-50 ultrasound system

Mindray Medical International Limited, a leading developer, manufacturer and marketer of medical devices worldwide, today announced the introduction of the company's new DP-50 ultrasound system in the United States. The black and white portable unit provides outstanding imaging quality in a compact system and is designed for use in numerous specialty markets.

From Mindray 16 Sep 2011

Researchers develop polymers that fluoresce in the presence of bacteria

Researchers at the University of Sheffield have developed polymers that fluoresce in the presence of bacteria, paving the way for the rapid detection and assessment of wound infection using ultra-violet light.

16 Sep 2011

Appeals court to take up Ariz. Medicaid challenge

The state appellate court will hear arguments next month on whether the governor can reduce enrollment in Medicaid.

16 Sep 2011

Teva to invest in CDI for development of novel antiviral drugs

Teva Pharmaceutical Industries Ltd. announced today that it has signed a collaboration option to license and share purchase agreements to invest in Cocrystal Discovery Inc. (CDI), a biopharmaceutical company focused on the discovery and development of novel antiviral therapeutics for the treatment of serious and chronic viral diseases.

16 Sep 2011

Cleveland Clinic receives NIH grant to study effectiveness of concussion diagnostic test

Researchers at Cleveland Clinic have received a grant from the National Institutes of Health (NIH) to continue studying the effectiveness of a blood test that conclusively identifies concussions in college football players.

16 Sep 2011

St. Jude Medical to again participate in Asia-Pacific Heart Rhythm Society Scientific Session

St. Jude Medical, Inc., a global medical device company, is pleased to again participate in the Asia-Pacific Heart Rhythm Society Scientific Session (APHRS), which is being held this year in conjunction with the Japanese Heart Rhythm Society (JHRS) and the Japanese Society of Electrocardiology (JSE) in Fukuoka, Japan.

16 Sep 2011

Loop-mediated Isothermal Amplification test for human African trypanosomiasis

The Geneva-based not-for-profit foundation FIND and Japanese diagnostics company Eiken announced today that a next-generation molecular test designed specifically for sleeping sickness - a deadly parasitic disease also known as human African trypanosomiasis (HAT) - is ready to enter accelerated field trials in sites across the Democratic Republic of Congo and Uganda.

16 Sep 2011

New nanopore sensor can lead to early detection of lung cancer

When lung cancer strikes, it often spreads silently into more advanced stages before being detected. In a new article published in Nature Nanotechnology, biological engineers and medical scientists at the University of Missouri reveal how their discovery could provide a much earlier warning signal.

16 Sep 2011

New insight into why some individuals may be more aggressive than others

Fluctuations of serotonin levels in the brain, which often occur when someone hasn't eaten or is stressed, affects brain regions that enable people to regulate anger, new research from the University of Cambridge has shown.

16 Sep 2011

Researchers identify promising new therapies for ependymoma

Researchers have identified promising new therapies for ependymoma, a rare tumor with few treatment options. St. Jude Children's Research Hospital investigators led the effort, which used a new, faster drug development system that combines the latest drug screening technology with the first accurate animal model of the tumor.

16 Sep 2011